Table 2 Peak of clusters showing significantly greater reduction in neural response on amisulpride relative to placebo compared to aripiprazole relative to placebo during reward outcome in whole brain analysis (FSL randomise: two-sided independent sample t-tests comparing amisulpride–placebo to aripiprazole–placebo, with 5000 permutations and FWE correction for multiple comparisons using threshold-free cluster enhancement at p <  0.05)

From: Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviour